Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H23N3O10.C6H8O6.Fe.Tc |
| Molecular Weight | 724.222 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Fe].[99Tc].OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.OC(=O)CN(CCN(CC(O)=O)CC(O)=O)CCN(CC(O)=O)CC(O)=O
InChI
InChIKey=LDVQRVOHMMYEBK-BNVFFUDCSA-N
InChI=1S/C14H23N3O10.C6H8O6.Fe.Tc/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;7-1-2(8)5-3(9)4(10)6(11)12-5;;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);2,5,7-10H,1H2;;/t;2-,5+;;/m.0../s1/i;;;1+1
DescriptionSources: https://www.hindawi.com/journals/stni/2014/839369/Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Sources: https://www.hindawi.com/journals/stni/2014/839369/
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | OSTEOLITE Approved UseUnknown Launch Date1977 |
|||
| Diagnostic | DRAXIMAGE MDP-10 Approved UseMDP-25 (Kit for the Preparation of Technetium Tc 99m Medronate) may be used as a bone imaging agent to delineate areas of altered osteogenesis. Launch Date1978 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL1201411
Created by
admin on Mon Mar 31 18:15:29 GMT 2025 , Edited by admin on Mon Mar 31 18:15:29 GMT 2025
|
PRIMARY | |||
|
100000092192
Created by
admin on Mon Mar 31 18:15:29 GMT 2025 , Edited by admin on Mon Mar 31 18:15:29 GMT 2025
|
PRIMARY | |||
|
007KG0HTO5
Created by
admin on Mon Mar 31 18:15:29 GMT 2025 , Edited by admin on Mon Mar 31 18:15:29 GMT 2025
|
PRIMARY | |||
|
76971971
Created by
admin on Mon Mar 31 18:15:29 GMT 2025 , Edited by admin on Mon Mar 31 18:15:29 GMT 2025
|
PRIMARY | |||
|
SUB15468MIG
Created by
admin on Mon Mar 31 18:15:29 GMT 2025 , Edited by admin on Mon Mar 31 18:15:29 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD